Capital Genomix To Launch New Gene Discovery System At California Venture Forum Presentation.Business Editors and Health/Medical Writers GAITHERSBURG, Md.--(BW HealthWire)--May 8, 2001 Capital Genomix Inc. will announce the commercial launch of GeneSystem320(TM), a revolutionary new gene discovery system, at its presentation before the California Venture Forum on May 17 at the Phoenix Club in Anaheim, Calif. GeneSystem320(TM) (GS320) enables the discovery of new genes as well as the study of existing genes using a simple and straightforward approach. It is currently being applied to research in diverse applications from the study of genes associated with breast cancer to those genes found to be associated with HIV HIV (Human Immunodeficiency Virus), either of two closely related retroviruses that invade T-helper lymphocytes and are responsible for AIDS. There are two types of HIV: HIV-1 and HIV-2. HIV-1 is responsible for the vast majority of AIDS in the United States. infected in·fect tr.v. in·fect·ed, in·fect·ing, in·fects 1. To contaminate with a pathogenic microorganism or agent. 2. To communicate a pathogen or disease to. 3. To invade and produce infection in. cells. Dr. Bill Hearl, president and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Capital Genomix, commented: "GeneSystem320 opens up a world of possibilities to the discovery research community by making true gene discovery research a reality. We expect our technologies to lead to significant opportunities for the development of new drugs and new diagnostic tools." The technology was licensed from the MD Anderson Cancer Institute and recently received broad patent protection in the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. (U.S. Patent 6,221,600). Dr. Jill Ray, vice president of R&D at Capital Genomix, summarized some of the advantages of GeneSystem320(TM) stating: "This technology moves the decision-making process back into the hands of the scientist by allowing them to decide which genes to study. "The flexibility of the GS320 array permits diverse approaches to the study of gene expression -- from all the genes in the cell down to a select, chosen few. As we move toward a fully automated au·to·mate v. au·to·mat·ed, au·to·mat·ing, au·to·mates v.tr. 1. To convert to automatic operation: automate a factory. 2. GS320 platform, we will be able to provide clients with rapid access to gene expression data on a wide array of cells and tissues." The first of the GeneSystem320(TM) product line is available from KPL KPL Khaosan Pathet Lao (News Agency, Laos) KPL Korporaal (Dutch) KPL Korporal (German) KPL Kansas Power & Light KPL Kerry Properties Limited KPL Kit Parts List (Gaithersburg) who recently took a non-exclusive license to the technology for sale to the research market. "We expect the GeneSystem320(TM) product line to become the cornerstone cornerstone Ceremonial building block, dated or otherwise inscribed, usually placed in an outer wall of a building to commemorate its dedication. Often the stone is hollowed out to contain newspapers, photographs, or other documents reflecting current customs, with a view to of our molecular biology molecular biology, scientific study of the molecular basis of life processes, including cellular respiration, excretion, and reproduction. The term molecular biology was coined in 1938 by Warren Weaver, then director of the natural sciences program at the Rockefeller product line," said Albert Perry, president of KPL. "This is an entirely new approach to the study of genes. KPL is excited to bring this important product line to life science researchers." For more information, call 240/401-2801 or visit Capital Genomix online at http://www.capitalgenomix.com. Capital Genomix is a privately held biotechnology company with offices and laboratories located at its facilities in Gaithersburg. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion